Margaret Mitchell: Unfiltered

Vasco Electronics unveils AI that translates presentations in real-time and mimics vocal emotion, pushing the boundaries of multilingual interaction.

Setrusumab, a promising drug for Osteogenesis Imperfecta, failed to reduce fractures in key trials, triggering a market collapse and strategic overhaul.

Ekinops' new high-density module simplifies complex networks, cuts costs, and paves the way for terabit-speed connectivity in the 5G and AI era.

Danish Aerospace Company appoints HC Andersen Capital as its new Certified Advisor, a proactive move prompted by Baker Tilly's exit from the CA market.

As pharma sells GLP-1s directly to patients, doctors are split on the new model. Is it a lifeline for access or a risk to integrated patient care?

A renewed partnership between a top distributor and a leading tech platform signals a major digital evolution for Florida's beverage alcohol industry.

Semrush's new app brings live marketing data directly into ChatGPT, promising a new era of efficiency and reshaping the competitive SaaS battleground.

Leading wellness franchise Prime IV Hydration & Wellness lands major financing to accelerate its rapid expansion in the booming IV therapy market.

The insurance giant launches its first actively managed ETFs, TALV and TABD, leveraging expert sub-advisors to offer established strategies.

A new alliance between EMQ and Volt Active Data promises to deliver a unified device-to-decision platform for mission-critical IoT with unprecedented speed.

A familiar quit-smoking app has been rebuilt into a powerful research tool, powering Australia's largest cessation trial and setting a new standard.

A popular countertop choice is fueling a deadly, incurable lung disease among workers, sparking a public health crisis and a race for safer alternatives.

As AI adoption surges, one firm's rigorous SOC 2 compliance offers a new blueprint for trust in an era of high-stakes data and complex cyber threats.

From biopharma to webcomics, shareholder lawsuits reveal the perils of misleading investors. A look at four companies facing legal and financial fallout.

A new rapid saliva test from ImpetusDX promises to revolutionize oral care by linking gum health to systemic disease, but can it overcome market hurdles?

A new campaign tackles undiagnosed kidney disease. But is it just public health, or a savvy strategy to reshape a multi-billion dollar market?

With a key Australian security certification, Ivalua isn't just checking a box—it's executing a strategic disruption in government procurement.

BlockQuarry unveils a sleek new website for its US-made miner, but can this digital pivot overcome steep financial hurdles and disrupt a crowded market?

CodeSignal's new AI interviews candidates by phone in 20+ languages, promising a revolution in efficiency. But can it overcome the hurdles of bias and empathy?

A novel drug for heart failure shows promising safety and efficacy data, potentially disrupting a multi-billion dollar market and validating a key investor's strategy.